JW (Cayman) Therapeutics Co. Ltd
JWCTF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $744 | $490 | $669 | $781 |
| - Cash | $647 | $757 | $869 | $1,006 |
| + Debt | $372 | $422 | $381 | $319 |
| Enterprise Value | $470 | $155 | $181 | $94 |
| Revenue | $106 | $71 | $87 | $86 |
| % Growth | 48.9% | -17.8% | 0.8% | – |
| Gross Profit | $65 | $34 | $44 | $43 |
| % Margin | 61.2% | 47% | 50.4% | 50.4% |
| EBITDA | -$80 | -$186 | -$205 | -$225 |
| % Margin | -75.3% | -260.7% | -236% | -261.8% |
| Net Income | -$267 | -$350 | -$240 | -$388 |
| % Margin | -251.3% | -490.7% | -276.8% | -450.1% |
| EPS Diluted | -0.64 | -0.84 | -0.58 | -0.94 |
| % Growth | 23.8% | -44.8% | 38.3% | – |
| Operating Cash Flow | $0 | -$145 | -$188 | -$160 |
| Capital Expenditures | $0 | -$2 | -$3 | -$6 |
| Free Cash Flow | $0 | -$148 | -$191 | -$166 |